0 Comentários
0 Compartilhamentos
211 Visualizações
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça Login para curtir, compartilhar e comentar!
- Red Blood Cell Disorders: A Comprehensive Market Analysis of Autoimmune Hemolytic Anemia TherapyRed blood cell disorders encompass a wide range of conditions affecting the production, function, or lifespan of erythrocytes. Among these, autoimmune hemolytic anemia (AIHA) presents a unique clinical challenge due to its autoimmune nature, requiring therapies that modulate the immune system. The market for treating AIHA is expanding, driven by a rising incidence of autoimmune conditions,...0 Comentários 0 Compartilhamentos 187 Visualizações
- Autoimmune Biosimilar Drug Market Research Report: Growth Forecast, Competitive Analysis & Emerging OpportunitiesAutoimmune Biosimilar Drug Market According to the latest report published by Data Bridge Market Research, the Autoimmune Biosimilar Drug Market The global autoimmune biosimilar drug market size was valued at USD 415.80 million in 2025 and is expected to reach USD 879.70 million by 2033, at a CAGR of 9.80% during the forecast period The market growth is...0 Comentários 0 Compartilhamentos 513 Visualizações
- Autoimmune Blood Disorders: The ITP Therapeutics Market and Treatment InnovationsAutoimmune blood disorders, including immune thrombocytopenia, present significant challenges for patients and healthcare providers, requiring specialized diagnostic and therapeutic approaches. The autoimmune blood disorders treatment market is experiencing significant growth, with projections from USD 2.1 billion in 2025 to USD 3.5 billion by 2035, driven by increasing...0 Comentários 0 Compartilhamentos 106 Visualizações
- Biosimilars Market - Immunology Biosimilars and Autoimmune Disease ManagementMarket Overview The global Biosimilars Market is experiencing explosive growth driven by immunology biosimilar availability, autoimmune disease management evolution, and anti-TNF therapy cost reduction. The global biosimilars market is projected to exceed USD 30 billion through 2030, fueled by adalimumab biosimilar launch, etanercept biosimilar growth, and infliximab biosimilar expansion....0 Comentários 0 Compartilhamentos 220 Visualizações
- From Hospital to Home: The Expanding Role of Autoimmune Vascular Disease and Corticosteroid TreatmentThe delivery of giant cell arteritis care has expanded beyond traditional hospital settings, with patients increasingly receiving treatment in outpatient clinics and homecare environments. Autoimmune vascular disease management has evolved to meet the needs of these diverse settings, offering the efficacy, safety, and convenience needed for effective disease control across the care continuum....0 Comentários 0 Compartilhamentos 180 Visualizações
- How CD47 Antibody Therapies Are Advancing Cancer Immunotherapy, Autoimmune Disease Treatment, and Personalized MedicineThe global leukocyte surface antigen CD47 antibody market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of cancer and improve patient outcomes. The market was valued at USD 1.3 billion in 2025 and is projected to reach USD 3.5 billion by 2035, growing at a CAGR of 10.6%. The...0 Comentários 0 Compartilhamentos 2 Visualizações
- Humira Biosimilar Market to Grow at a CAGR of 22.1% Through 2032According to a new report published by Introspective Market Research, Humira Biosimilar Market by Product Type, Indication, and Distribution Channel, The Global Humira Biosimilar Market Size Was Valued at USD 0.72 Billion in 2023 and is Projected to Reach USD 4.34 Million by 2032, Growing at a CAGR of 22.1%. Introduction / Market Overview The Humira Biosimilar Market is...0 Comentários 0 Compartilhamentos 1062 Visualizações
- Lupus Market: A Comprehensive Analysis of a Growing Autoimmune Therapeutics SectorMarket Overview The Lupus Market is a significant and rapidly evolving segment of the autoimmune therapeutics landscape, addressing a complex and chronic inflammatory disease that affects millions worldwide. Systemic Lupus Erythematosus (SLE), the most common form, can impact multiple organ systems, requiring a diverse and often life-long treatment approach. The market is experiencing a...0 Comentários 0 Compartilhamentos 200 Visualizações
- Precision Targeting: How Monoclonal Antibody Therapy is Revolutionizing Autoimmune Disease TreatmentAutoimmune diseases, affecting approximately 5-8% of the global population, represent a significant and growing healthcare challenge. These chronic conditions occur when the immune system mistakenly attacks the body's own tissues, leading to inflammation, pain, and organ damage across conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel disease. The Autoimmune Monoclonal...0 Comentários 0 Compartilhamentos 170 Visualizações
Páginas Impulsionadas